Sanofi Pasteur has signed a deal with SK Chemicals to license cell culture vaccine technology as the US is hit by a flu epidemic, reportedly one of the worst in recent history, which has highlighted the need for a universal vaccine and more potent flu shots produced in cells instead of eggs. To get exclusive
The Parker Institute for Cancer Immunotherapy, Bristol-Myers Squibb Company and the Cancer Research Institute (CRI) today announced a multi-year clinical research collaboration to coordinate and rapidly initiate clinical Immuno-Oncology (I-O) studies across the Parker Institute and CRI networks. Bristol-Myers Squibb will work closely with prominent Parker Institute and CRI scientists and researchers, soliciting clinical research
Pfizer Inc. announced the recent publication of a post-hoc analysis of data from three studies of VYNDAQEL in patients with mild transthyretin familial amyloid polyneuropathy (TTR-FAP). The analysis, which included patients with the Val30Met mutation treated over varying periods of up to 5 and a half years, showed that treatment with VYNDAQEL initiated during the
In recognition of International Clinical Trials day, Clinical Professionals invites Deborah Bruce, Training Academy Manager, to provide some personal insight and reflect on the importance of clinical trials. As today is International Clinical Trials Day, which marks the anniversary of the first clinical trial by James Lind in 1747, I find myself reflecting on my
